Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAV
3201
DELISTED
Advantage Oil & Gas Ltd
AAV
| $91K | ﹤0.01% |
+13,496
| New | +$94.6K |
|
|
ALPN
3202
DELISTED
Alpine Immune Sciences Inc
ALPN
| $90K | ﹤0.01% |
+10,021
| New | +$200K |
|
3203
Harvard Bioscience
HBIO
$34.4M
| $88K | ﹤0.01% |
2,897
-1,713
| -37% | -$43.6K |
|
3204
Asure Software
ASUR
$251M
| $86K | ﹤0.01% |
+10,066
| New | +$78.6K |
|
|
MCN
3205
Madison Covered Call & Equity Strategy Fund
MCN
$119M
| $85K | ﹤0.01% |
+11,077
| New | +$86.2K |
|
3206
Enphase Energy
ENPH
$4.91B
| $84K | ﹤0.01% |
83,369
-46,131
| -36% | -$52.9K |
|
|
UNIS
3207
DELISTED
Unilife Corporation
UNIS
| $82K | ﹤0.01% |
35,869
-27,931
| -44% | -$65.4K |
|
|
STKL
3208
DELISTED
SunOpta
STKL
| $81K | ﹤0.01% |
+11,521
| New | +$80.2K |
|
|
TRIL
3209
DELISTED
Trillium Therapeutics Inc.
TRIL
| $81K | ﹤0.01% |
14,300
-2,910
| -17% | -$29K |
|
|
DWCH
3210
DELISTED
Datawatch Corp
DWCH
| $80K | ﹤0.01% |
+14,491
| New | +$96.1K |
|
3211
Zevra Therapeutics
ZVRA
$692M
| $79K | ﹤0.01% |
1,665
+100
| +6% | +$6.14K |
|
|
HIVE
3212
DELISTED
Aerohive Networks
HIVE
| $79K | ﹤0.01% |
13,776
-160,340
| -92% | -$887K |
|
|
SEAC
3213
DELISTED
Seachange International Inc
SEAC
| $77K | ﹤0.01% |
1,663
-6,437
| -79% | -$336K |
|
|
PTN
3214
Palatin Technologies
PTN
$18.1M
| $76K | ﹤0.01% |
+120
| New | +$83.5K |
|
3215
SCYNEXIS
SCYX
$52.3M
| $74K | ﹤0.01% |
291
-157
| -35% | -$46K |
|
3216
Compugen
CGEN
$245M
| $73K | ﹤0.01% |
14,328
-78,392
| -85% | -$469K |
|
|
SRRA
3217
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $73K | ﹤0.01% |
+1,225
| New | +$76.4K |
|
|
IVTY
3218
DELISTED
Invuity, Inc
IVTY
| $72K | ﹤0.01% |
12,479
-10,816
| -46% | -$90.5K |
|
3219
Cytosorbents Corp
CTSO
$23.3M
| $71K | ﹤0.01% |
+13,000
| New | +$71.2K |
|
3220
GEE Group
JOB
$28M
| $71K | ﹤0.01% |
16,041
-8,320
| -34% | -$39.5K |
|
3221
Codexis
CDXS
$182M
| $70K | ﹤0.01% |
15,112
-32,139
| -68% | -$151K |
|
|
WORX
3222
DELISTED
SCWORX CORP NEW
WORX
| $70K | ﹤0.01% |
+4
| New | +$68K |
|
3223
Zedge
ZDGE
$37.8M
| $69K | ﹤0.01% |
21,885
-10,059
| -31% | -$32.4K |
|
|
YDKG
3224
Yueda Digital Holding
YDKG
$5.64M
| $68K | ﹤0.01% |
+14
| New | +$82.2K |
|
|
GFN
3225
DELISTED
General Finance Corporation
GFN
| $68K | ﹤0.01% |
+12,218
| New | +$55K |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.